Apollo Health Ventures is a transatlantic early-stage Venture Capital firm actively co-founding and investing in transformative healthcare companies targeting age-related diseases and aging itself. The firm believes biotechnology is the solution for a healthier lifespan and reduced healthcare spending. By investing in and enabling transformative healthcare companies, Apollo aims to impact human health within the next 10 years.
Bevorzugte Reifephase für die erste Finanzierung.
age-related diseases, aging, biotechnology, therapeutics for inflammatory and fibrotic diseases, oncology
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...